Our results have suggested that T2D complicated with metabolic syndrome, such as dyslipidaemia and obesity, could induce EMT with a reduction in the expression of E−cadherin and an increase in the expression of vimentin through RAGE activation in PSCs. This evidence concerns the gene VIM and type 2 diabetes mellitus.